US stocks have risen this year, but traders are hedging against big swings induced by Trump’s erratic policymaking ...

While nobody knows what the rest of the year has in store for the stock market, longtime investor Warren Buffett has some ...

It's past the peak of earnings season and results have been largely favorable, with 60% of companies so far beating sales ...

Investors are now betting that the Federal Reserve will cut interest rates just once more this year, a drastic shift in expectations since late 2024.

Investor confidence wanes as market volatility slows active client additions and new demat account openings, impacting major brokers.

In a remarkable display of market confidence, Ares Acquisition Corporation II (AACT) stock has reached an all-time high, touching $11.06 in a recent trading session. With a market capitalization of ...

Gilead Sciences (GILD) could open near nine-year highs after beating fourth-quarter earnings and revenue estimates ...

This morning, the S&P 500 futures contract is pulling back from the 6,100 level following the consumer inflation report.

The company reported $261 million in revenue and adjusted earnings of $0.09 per share, slightly above analysts' consensus ...

BigBear.ai (NYSE: BBAI) has been in highly volatile in Monday's trading, but it's currently posting gains in the session. The ...

Investors need to pay close attention to Canadian Imperial Bank of Commerce (CM) stock based on the movements in the options ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.